about
Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products includ...
Read More
3.33
-0.20
(-5.67%)
101.1K
XNAS Volume
XNAS 29 Aug, 2025 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Genelux Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..